The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children

被引:32
作者
Islek, Ali [1 ]
Sayar, Ersin [1 ]
Yilmaz, Aygen [1 ]
Baysan, Betil Ozhak [2 ]
Mutlu, Derya [2 ]
Artan, Reha [1 ]
机构
[1] Akdeniz Univ, Fac Med, Dept Pediat Gastroenterol, TR-07058 Antalya, Turkey
[2] Akdeniz Univ, Fac Med, Dept Clin Microbiol, TR-07058 Antalya, Turkey
关键词
Bifidobacterium lactis B94; inulin; acute gastroenteritis; childhood; ACUTE GASTROENTERITIS; LACTOBACILLUS-ACIDOPHILUS; SACCHAROMYCES-BOULARDII; PROBIOTICS; PREBIOTICS; OLIGOSACCHARIDES; METABOLISM;
D O I
10.5152/tjg.2014.14022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In contrast to many other studies of probiotic species, the number of publications evaluating Bifidobacterium lactis and its combinations with prebiotics as treatments for acute infectious diarrhea is limited. We investigated the synbiotic effects of B. lactis B94 plus inulin on acute infectious diarrhea. Materials and Methods: The study was conducted on children with acute diarrhea between the ages of 2 and 60 months. The patients were administered 5x10(10) colony-forming units (CFU) of B. lactis B94 plus 900 mg inulin or placebo, once a day for five days. Stools were examined for Rotavirus, Adenovirus, Entamoeba histolytica, Salmonella, Shigella, Campylobacter, Clostridium difficile, Cryptosporidium, and parasites. Results: We examined 79 patients in the synbiotic group and 77 patients in the placebo group. The duration of diarrhea was significantly reduced in the synbiotic group in comparison with the placebo group (3.9 +/- 1.2 days vs. 5.2 +/- 1.3 days, respectively; p<0.001). Moreover, the number of diarrheal stools on the third day was significantly lower in the synbiotic group than in the placebo group (5.5 +/- 2.9 vs. 8.3 +/- 3.01, respectively; p<0.001). Diarrhea in the synbiotic-group patients with rotavirus infection was of a significantly shorter duration (3.2 +/- 1.3 days vs. 5.2 +/- 1.3 days, respectively; p=0.001). Duration of diarrhea in patients who started the synbiotic treatment within the first 24 h was shorter than that in the patients who started the treatment later (3.9 +/- 1.1 days vs. 4.8 +/- 1.8 days, respectively; p=0.002). Conclusion: Treatment with 5 x 10(10) CFU of B. lactis B94 plus 900 mg inulin shortened the duration of acute watery diarrhea by an average of 31 h. This decrease was most pronounced in cases of Rotavirus diarrhea.
引用
收藏
页码:628 / 633
页数:6
相关论文
共 32 条
[1]  
ALLEN SJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003048.PUB2
[2]   Probiotics for treating acute infectious diarrhoea [J].
Allen, Stephen J. ;
Martinez, Elizabeth G. ;
Gregorio, Germana V. ;
Dans, Leonila F. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (11)
[3]   Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) [J].
Arunachalam, K ;
Gill, HS ;
Chandra, RK .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2000, 54 (03) :263-267
[4]   Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life [J].
Bakker-Zierikzee, AM ;
Alles, MS ;
Knol, J ;
Kok, FJ ;
Tolboom, JJM ;
Bindels, JG .
BRITISH JOURNAL OF NUTRITION, 2005, 94 (05) :783-790
[5]   Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition [J].
Braegger, Christian ;
Chmielewska, Anna ;
Decsi, Tamas ;
Kolacek, Sanja ;
Mihatsch, Walter ;
Moreno, Luis ;
Piescik, Malgorzata ;
Puntis, John ;
Shamir, Raanan ;
Szajewska, Hania ;
Turck, Dominique ;
van Goudoever, Johannes .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 52 (02) :238-250
[6]   Probiotics in primary care pediatrics [J].
Cabana, Michael D. ;
Shane, Andi L. ;
Chao, Cewin ;
Oliva-Hemker, Maria .
CLINICAL PEDIATRICS, 2006, 45 (05) :405-410
[7]   Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects [J].
De Preter, V ;
Vanhoutte, T ;
Huys, G ;
Swings, J ;
Rutgeerts, P ;
Verbeke, K .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (07) :963-974
[8]   Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea [J].
Dinleyici, Ener Cagri ;
Eren, Makbule ;
Ozen, Metehan ;
Yargic, Zeynel Abidin ;
Vandenplas, Yvan .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (04) :395-410
[9]   Probiotics and prebiotics in gastrointestinal disorders [J].
Fedorak, RN ;
Madsen, KL .
CURRENT OPINION IN GASTROENTEROLOGY, 2004, 20 (02) :146-155
[10]   A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011 [J].
Foster, L. M. ;
Tompkins, T. A. ;
Dahl, W. J. .
BENEFICIAL MICROBES, 2011, 2 (04) :319-334